Jeffrey Davis
@JeffreyLDavis44
Health Policy Director @mcdermottplus. Husband, father of two, Duke basketball super fan. Opinions are my own.
ID:4900147719
https://www.mcdermottplus.com/blog_category/regs-eggs/ 12-02-2016 03:33:17
1,7K Tweets
1,4K Followers
4,3K Following
Yes, I definitely recommend that folks read the Chris Hamby article from the The New York Times.
nytimes.com//2024/04/07/us…
Also, as Ed Gaines notes, the article notes that U.S. Department of Labor only has one investigator for every 8,800 employer-based health plans. Proper oversight of these plans is…
Great summary of the MA and Part D final rule by Bridget Early at InsideHealthPolicy !
CMS Brings Back 2024 Proposal To Crack Down On 3rd-Party Marketers In 2025 MA Rule | InsideHealthPolicy.com insidehealthpolicy.com/daily-news/cms…
Today, April 4, 2024, CMSGov issued a final rule that institutes changes to the Medicare Advantage (MA) and the Medicare Prescription Drug (Part D) Programs.
· The Final Rule can be found here: public-inspection.federalregister.gov/2024-07105.pdf
· A fact sheet highlighting the policies in the rule is…
“This drug is expensive,” Jeffrey Davis from McDermott+Consulting said. “If millions of people are covered, it could increase premiums going forward.”
Experts warn of Medicare premium hikes to cover Wegovy for heart risks nbcnews.com/health/health-… via @nbcnews